MedJev does not generate sentences to decide whether a patient should be admitted. It is an open System One model that answers structured clinical questions in a single pass, without producing text. The results bring it close to GPT-4 on some benchmarks: 72.5% on MedQA, 75.4% on USMLE, and 80.1% on NEJM. But the most interesting result is not the raw score.

MedJev runs locally on a laptop. That changes the calculation for anyone deploying clinical tools: no calls to a remote API, no movement of patient records to the cloud, and a lighter inference pipeline. On medical knowledge tasks, calibration is strong: expected calibration error ranges from 0.028 to 0.063. On patient-level tasks, the picture is more mixed. For in-hospital mortality, the model reaches an AUROC of 0.926, beating XGBoost at 0.902. For emergency department triage admission, however, it remains below a supervised model: 0.745 versus 0.809. Calibration worsens sharply, with an ECE of 0.286.

This is where the structural contribution lies: a lightweight two-parameter recalibration using only 50 to 200 locally labeled examples brings ECE down to 0.007. The point is not merely technical. It indicates that the clinical problem is not necessarily model training, but adaptation to the local patient population. A hospital can start from a zero-shot model and adjust probabilities with a small internal sample, avoiding heavy fine-tuning or shared training infrastructure.

Second-order implications are concrete. Local healthcare system builders can reduce dependence on cloud providers and centralized training pipelines. But the new bottleneck becomes the quality of the calibration set: 50 to 200 cases can shift the average, but they cannot correct systematic errors on rare subgroups or biases already present in the model. This is not a free solution; it shifts the cost from compute to local labeling and data governance.

There is also a market signal. Medical knowledge benchmarks reward accuracy, but the paper shows that patient-level results require calibration metrics and operational performance. A model that beats XGBoost on mortality but loses on triage is not simply better or worse: it suits different contexts. Local calibration becomes part of deployment, not an after-the-fact check.

For those evaluating on-premise deployment, trade-offs exist among computational cost, data control, and predictive quality. AI-RADAR collects analytical frameworks at /llm-onpremise to assess these aspects without reducing them to a single benchmark.